Hepatic capsule haemorrhage due to HELLP syndrome managed with recombinant factor VIIa

Author： Gandhimathi K McLornan D O'Neill F

ISSN： 0956-3075

Source： Clinical Intensive Care, Vol.15, Iss.1, 2004-03, pp. : 15-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic haemorrhage during toxaemia and HELLP syndrome

By BETROSIAN A P KOFINAS G KOSKINAS J BALLA M PAPANIKOLAOU M GEORGIADIS G C

Clinical Intensive Care, Vol. 9, Iss. 4, 1998-08 ,pp. : 161-163

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Recombinant Factor VIIa

By Dunn C.J. Spencer C.M.

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 71-77

Adis International

Access to resources Recommend Favorite

Recombinant Factor VIIa: A Viewpoint by Amy D. Shapiro

By Shapiro A.D.

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 78-79

Adis International

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders

By Croom Katherine F. McCormack Paul L.

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 121-136

Adis International

Access to resources Recommend Favorite

Placenta accreta: adherent placenta due to Asherman syndrome

Clinical Case Reports, Vol. 3, Iss. 3, 2015-03 ,pp. : 175-178

John Wiley & Sons Inc

Access to resources Recommend Favorite